The Structural Biology Shared Resource provides state-of-the-art infrastructure and expertise needed for high quality protein production and high resolution structure determination by NMR and X-ray crystallography. These capabilities are complemented by significant strengths in cryo-electron microscopy, electron paramagnetic resonance, a wide range of vibrational spectroscopies, computational biology and unique macromolecular foot printing approaches at the College and AECC. Through the New York Structural Genomics Research Consortium (NYSGRC), AECC investigators have access to -25-30 shifts (8 hour blocks) on the X29 insertion device at the National Synchrotron Light Source (NSLS), Brookhaven National Laboratory, as well as outstanding access to the LRL-CAT beamline (administered by Eli Lilly &Co.) at the Advanced Photon Source (APS), which provides FEDEX crystallographic service at one of the premiere beamlines in the world. Moreover, through membership in the New York Structural Biology Center, AECC investigators have access to the X4A bending magnet beamline at NSLS. These arrangements ensure that access to data collection resources is never rate limiting. There is also in-house Rigaku rotating anode/image plate data collection capabilities essential for characterization and screening of samples prior to synchrotron analysis. NMR capabilities at Einstein consists of one 300 MHz and two 600 MHz NMR spectrometers, with a cryoprobe on one of the 600s. AECC investigators also have full access to the NYSBC making available two 900 MHz and three 800 MHz instruments, all with cryoprobes, and one 750 MHz solid state NMR spectrometer. As proposed in the previous application, the Structural Biology Shared Resource has established unique capabilities, including considerable automation and expertise, which support large-scale and high-throughput protein production in E. coli, insect cell and mammalian expression platforms. Additional automation supports high-throughput protein crystallization and crystal imaging. The Facility is now working to implement modest fragment-based screening capabilities to leverage the numerous proteins and structures being produced, and is positioned to exploit NSLS-II, the new third generation synchrotron facility being constructed at Brookhaven National Laboratory. Together, these capabilities provide the AECC community with a powerful infrastructure that will make it possible to realize protein reagents and structural information to drive a wide range of biology and therapeutics.

Public Health Relevance

The Structural Biology Shared Resource provides unparalleled expertise and instrumentation for the production of protein reagents and high resolution structure determination to support the translational research mission and goals of the Albert Einstein Cancer Center (AECC). As an NCI-designated Cancer Center, AECC contributes to the national effort to reduce morbidity and mortality from cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013330-41
Application #
8753317
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
41
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
City
Bronx
State
NY
Country
United States
Zip Code
10461
Agalliu, Ilir; Chen, Zigui; Wang, Tao et al. (2018) Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer. Cancer Epidemiol Biomarkers Prev 27:1168-1175
Bhargava, Ragini; Sandhu, Manbir; Muk, Sanychen et al. (2018) C-NHEJ without indels is robust and requires synergistic function of distinct XLF domains. Nat Commun 9:2484
Collu, Giovanna M; Jenny, Andreas; Gaengel, Konstantin et al. (2018) Prickle is phosphorylated by Nemo and targeted for degradation to maintain Prickle/Spiny-legs isoform balance during planar cell polarity establishment. PLoS Genet 14:e1007391
Doyle, Christopher R; Moon, Jee-Young; Daily, Johanna P et al. (2018) A Capsular Polysaccharide-Specific Antibody Alters Streptococcus pneumoniae Gene Expression during Nasopharyngeal Colonization of Mice. Infect Immun 86:
Anayannis, Nicole V; Schlecht, Nicolas F; Ben-Dayan, Miriam et al. (2018) Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma. PLoS One 13:e0191581
Stepankova, Martina; Bartonkova, Iveta; Jiskrova, Eva et al. (2018) Methylindoles and Methoxyindoles are Agonists and Antagonists of Human Aryl Hydrocarbon Receptor. Mol Pharmacol 93:631-644
Maggi, Elaine C; Gravina, Silvia; Cheng, Haiying et al. (2018) Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model. Front Genet 9:6
Ingram, Jessica R; Blomberg, Olga S; Rashidian, Mohammad et al. (2018) Anti-CTLA-4 therapy requires an Fc domain for efficacy. Proc Natl Acad Sci U S A 115:3912-3917
Dulyaninova, Natalya G; Ruiz, Penelope D; Gamble, Matthew J et al. (2018) S100A4 regulates macrophage invasion by distinct myosin-dependent and myosin-independent mechanisms. Mol Biol Cell 29:632-642
Chen, Zigui; Schiffman, Mark; Herrero, Rolando et al. (2018) Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology 516:86-101

Showing the most recent 10 out of 1508 publications